JPRN-UMIN000041205
已完成
未知
A retrospective study to evaluate the predictive ability of a DNA methylation status-based diagnostic method for the sensitivity of anti-EGFR treatment in metastatic colorectal cancer - Observational study on a method for predicting the efficacy of anti-EGFR treatment for colorectal cancer
Institute of Development, Aging and Cancer (IDAC), Tohoku University0 个研究点目标入组 241 人2020年7月24日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Metastatic colorectal cancer
- 发起方
- Institute of Development, Aging and Cancer (IDAC), Tohoku University
- 入组人数
- 241
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
DNA methylation status may be a predictor of therapeutic response to anti-EGFR antibody drugs in the first-line treatment of metastatic colorectal cancer.
研究者
入排标准
入选标准
- 未提供
排除标准
- •Patients who received anti\-EGFR antibodies in the first or second line of treatment. Cases in which the patient is unable to submit the required amount of tissue samples from the primary tumor for measurement of methylation status. Cases considered by the attending physician to be unsuitable for enrollment in this study.
结局指标
主要结局
未指定
相似试验
已完成
不适用
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With OsteosarcomaLocalized OsteosarcomaMetastatic OsteosarcomaOsteoblastic OsteosarcomaRecurrent OsteosarcomaNCT01374672Children's Oncology Group20
已完成
不适用
Prognostic Molecular Markers in Patients With Myelodysplastic SyndromeMyelodysplastic SyndromeNCT02060409Samsung Medical Center58
已完成
2 期
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.Metastatic Esophageal CancerGastroesophageal CancerGastric CancerNCT01715233Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins27
Unknown
不适用
cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation OperationLung CancerNCT04413656Shanghai Chest Hospital90
已完成
不适用
The Use Of L-Methylfolate As A Treatment For DepressionDepressionNCT02133898University of Florida57